Malaria
FDA Approval Announced for Malarone
Published in TB and Outbreaks Week, August 1st, 2000
The drug, manufactured by Glaxo Wellcome Inc., Research Triangle Park, North Carolina, will be available in pharmacies in mid-August 2000. Malarone is a combination of atovaquone and proguanil HCL. Atovaquone is currently marketed in the United States under the trade name Mepron for Pneumocystis carinii pneumonia. Proguanil was approved in the U.S. in 1948 for use in malaria. Because it was not widely used in this country, it ceased to be marketed here in the 1970s. It continues to be...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Enteric Disease
Scientists in Japan Identify Unique Phage on Outbreak Vibrio Species - Tuberculosis
Mycobacterium bovis a Leading Cause of TB at Mexico-U.S. Border - Education and Prevention
Testing, Counseling Advocated to Slow HIV Epidemic in Developing Countries - Epidemiology
Scientists Describe Enterovirus 71 Outbreak in Children in Taiwan - Helicobacter pylori
Microbe that Causes Ulcers Seen in Many Italian Hepatitis Patients - Immunization
Hepatitis B Vaccination for Asian and Pacific Islander Children Emphasized - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
